Inhibition of 11β‐hydroxysteroid dehydrogenase‐1 (
11β‐HSD1
) with
AZD4017
in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: a randomized, double‐blind, placebo‐controlled, phase
II
study
2014 ◽
Vol 99
(3)
◽
pp. 535-542
◽
2004 ◽
Vol 3
(3)
◽
pp. 108-112
◽
2018 ◽
Vol 8
(2)
◽
pp. 307-317
◽
2016 ◽
Vol 21
(1)
◽
pp. 106
◽